Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis.

Abstract:

:Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer among men in the developed world. There is a need, for both clinical and scientific reasons, to find markers to identify patients with aggressive disease as early as possible, and to understand the events leading to malignant transformation and susceptibility to metastasis. We report the first large-scale gene expression analysis of a unique HNSCC location, the hypopharynx. Four normal and 34 tumour samples were analysed with 12 600 gene microarrays. Clusters of differentially expressed genes were identified in the chromosomal regions 3q27.3, 17q21.2-q21.31, 7q11.22-q22.1 and 11q13.1-q13.3, which, interestingly, have already been identified by comparative genomic hybridization (CGH) as major regions of gene amplification. We showed that six overexpressed genes (EIF4G1, DVL3, EPHB4, MCM7, BRMS1 and SART1) located in these regions are indeed amplified. We report 119 genes that are highly differentially expressed between 'early' tumours and normal samples. Of these, we validated by quantitative PCR six novel poorly characterized genes. These genes are potential new markers of HNSCC. Comparing patients with relatively nonaggressive and aggressive tumours (without or with clinical evidence of metastasis 3 years after surgery), we identified 164 differentially expressed genes potentially involved in the acquisition of metastatic potential. This study contributes to the understanding of HNSCC, staging patients into prognostic groups and identifying high-risk patients who may benefit from more aggressive treatment.

journal_name

Oncogene

journal_title

Oncogene

authors

Cromer A,Carles A,Millon R,Ganguli G,Chalmel F,Lemaire F,Young J,Dembélé D,Thibault C,Muller D,Poch O,Abecassis J,Wasylyk B

doi

10.1038/sj.onc.1207345

subject

Has Abstract

pub_date

2004-04-01 00:00:00

pages

2484-98

issue

14

eissn

0950-9232

issn

1476-5594

pii

1207345

journal_volume

23

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth.

    abstract::Triple negative breast cancer (TNBC) refers to tumors that do not express clinically significant levels of estrogen and progesterone receptors, and lack membrane overexpression or gene amplification of ErbB-2/HER2, a receptor tyrosine kinase. Transcriptome and proteome heterogeneity of TNBC poses a major challenge to ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01430-9

    authors: Chervo MF,Cordo Russo RI,Petrillo E,Izzo F,De Martino M,Bellora N,Cenciarini ME,Chiauzzi VA,Santa María de la Parra L,Pereyra MG,Güttlein LN,Podhajcer OL,Daniotti JL,Dupont A,Barchuk S,Figurelli S,Lopez Della Vecchia D,

    更新日期:2020-09-01 00:00:00

  • Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration.

    abstract::Proteinase-activated receptor 2 (PAR2) is a G protein-coupled receptor that is activated by trypsin-like proteinases. PAR2 is detected in breast tumor specimens; however, it is not clear how PAR2 level in breast cancer cell/tissues compares with normal cell/tissues. Here, we show the elevation of PAR2 protein level in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.163

    authors: Su S,Li Y,Luo Y,Sheng Y,Su Y,Padia RN,Pan ZK,Dong Z,Huang S

    更新日期:2009-08-27 00:00:00

  • Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.

    abstract::Although activation of the STAT3 pathway has been associated with tumor progression in a wide variety of cancer types (including ovarian cancer), the precise mechanism of invasion and metastasis due to STAT3 are not fully delineated in ovarian cancer. We found that pSTAT3 Tyr705 is constitutively activated in patient ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.197

    authors: Saini U,Naidu S,ElNaggar AC,Bid HK,Wallbillich JJ,Bixel K,Bolyard C,Suarez AA,Kaur B,Kuppusamy P,Hays J,Goodfellow PJ,Cohn DE,Selvendiran K

    更新日期:2017-01-12 00:00:00

  • Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.

    abstract::BRCA1 mutation carriers have an increased susceptibility to breast and ovarian cancer. Excision of exon 11 of Brca1 in the mouse, using a conditional knockout (Cre-loxP) approach, results in mammary tumor formation after long latency. To characterize the genomic instability observed in these tumors, to establish a com...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205636

    authors: Weaver Z,Montagna C,Xu X,Howard T,Gadina M,Brodie SG,Deng CX,Ried T

    更新日期:2002-08-01 00:00:00

  • Sp1 expression regulates lung tumor progression.

    abstract::The role of specificity protein 1 (Sp1) in controlling gene expression in lung tumor development and metastasis is not well understood. In this study, we showed that the Sp1 level was highly increased and required for lung tumor growth in transgenic mice bearing Kras-induced lung tumors under the control of doxycyclin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.568

    authors: Hsu TI,Wang MC,Chen SY,Yeh YM,Su WC,Chang WC,Hung JJ

    更新日期:2012-08-30 00:00:00

  • HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer.

    abstract::Hepatitis B virus (HBV) infection is a major risk factor worldwide for the development of hepatocellular carcinoma (HCC). Integrated HBV DNA fragments, often highly rearranged, are frequently detected in HCC. In woodchuck, the viral enhancer plays a central role in hepatocarcinogenesis, but in humans the mechanism of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204879

    authors: Shamay M,Agami R,Shaul Y

    更新日期:2001-10-18 00:00:00

  • Transfection of K-rasAsp12 cDNA markedly elevates IL-1beta- and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cells.

    abstract::Activating mutations of K-ras are frequent in colon tumors and aberrant crypt foci, and may play important roles in colon carcinogenesis. Here, we investigated the effects of a K-ras codon 12 mutation on inducible nitric oxide synthase (iNOS) expression. When rat intestinal epithelial cells (IEC-6) were transfected wi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207051

    authors: Takahashi M,Mutoh M,Shoji Y,Kamanaka Y,Naka M,Maruyama T,Sugimura T,Wakabayashi K

    更新日期:2003-10-23 00:00:00

  • Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.

    abstract::Constitutive activation of the phosphoinositide 3-kinase (PI3K)-AKT pathway is observed in up to 70% of acute myelogenous leukemia. To investigate the relevance of an intrinsic PI3K-AKT pathway activation in hematopoietic malignancies, we analysed the effect of point mutations in the catalytic (p110alpha) and regulato...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.40

    authors: Horn S,Bergholz U,Jücker M,McCubrey JA,Trümper L,Stocking C,Bäsecke J

    更新日期:2008-07-03 00:00:00

  • The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor.

    abstract::The mixed lineage leukemia (MLL) gene at chromosome band 11q23 is commonly involved in reciprocal translocations that are detected in acute leukemias. Evidence suggests that the resulting MLL fusion genes contribute to leukemogenesis. AF9 is a common MLL fusion partner in acute myeloid leukemia. The AF9 protein functi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206361

    authors: Srinivasan RS,de Erkenez AC,Hemenway CS

    更新日期:2003-05-29 00:00:00

  • Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma.

    abstract::Ectopic expression of metabotropic glutamate receptor subtype 1 (mGluR1) in mouse melanocytes induces melanoma formation. Although requirement of mGluR1 for development of melanoma in the initial stage has been demonstrated, its role in melanoma growth in vivo remains unclear. In this study, we developed novel transge...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.329

    authors: Ohtani Y,Harada T,Funasaka Y,Nakao K,Takahara C,Abdel-Daim M,Sakai N,Saito N,Nishigori C,Aiba A

    更新日期:2008-12-04 00:00:00

  • FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.

    abstract::Understanding the molecular mechanisms that underlie the aggressive behavior and relapse of breast cancer may help in the development of novel therapeutic interventions. CUB-domain-containing protein 1 (CDCP1), a transmembrane adaptor protein, is highly maintained and required in the context of cellular metastatic pot...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0372-3

    authors: Cui YH,Kim H,Lee M,Yi JM,Kim RK,Uddin N,Yoo KC,Kang JH,Choi MY,Cha HJ,Kwon OS,Bae IH,Kim MJ,Kaushik N,Lee SJ

    更新日期:2018-10-01 00:00:00

  • Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6.

    abstract::The Kruppel-like transcription factor KLF6 is a novel tumor-suppressor gene mutated in a significant fraction of human prostate cancer. It is localized to human chromosome 10p14-15, a region that displays frequent loss of heterozygosity in glioblastoma multiforme (GBM). Indeed, mutations of the KLF6 gene have recently...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207662

    authors: Kimmelman AC,Qiao RF,Narla G,Banno A,Lau N,Bos PD,Nuñez Rodriguez N,Liang BC,Guha A,Martignetti JA,Friedman SL,Chan AM

    更新日期:2004-06-24 00:00:00

  • Temporal patterns of A-myb and B-myb gene expression during testis development.

    abstract::We recently reported the cloning and sequencing of the mouse A-myb proto-oncogene cDNA and the abundant expression of this mRNA primarily in the testis of adult mice. The A-myb mRNA is detectable by in situ hybridization specifically in the spermatogenic cells, and is downregulated during terminal differentiation. A l...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Latham KE,Litvin J,Orth JM,Patel B,Mettus R,Reddy EP

    更新日期:1996-09-19 00:00:00

  • Activation-dependent degradation of protein kinase C eta.

    abstract::Prolonged activation of protein kinase Cs (PKCs) by long-term treatment of cells with phorbol ester tumor promoters down-regulates the expression of many PKCs. To investigate the molecular mechanisms involved in the down-regulation of PKC eta, we expressed the novel PKCs eta and θ and various mutant forms in bab...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203779

    authors: Kang BS,French OG,Sando JJ,Hahn CS

    更新日期:2000-08-31 00:00:00

  • Characterization of TIS7, a gene induced in Swiss 3T3 cells by the tumor promoter tetradecanoyl phorbol acetate.

    abstract::We report here the nucleic acid sequence and deduced amino acid sequence of a cDNA for TIS7, a gene induced by mitogens in 3T3 cells and by nerve growth factor in PC12 pheochromocytoma cells. A fragment of the TIS7 gene has previously been cloned from murine fibroblast cells infected with Newcastle Disease Virus. The ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Varnum BC,Lim RW,Herschman HR

    更新日期:1989-10-01 00:00:00

  • EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms.

    abstract::Amplification and rearrangements of the epidermal growth factor receptor (EGFR) gene are frequently found in glioblastoma multiforme (GBM). The most common variant is EGFR variant III (EGFRvIII). Research suggests that EGFRvIII could be a marker for a cancer stem cell or tumor-initiating population. If amplification a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.280

    authors: Del Vecchio CA,Giacomini CP,Vogel H,Jensen KC,Florio T,Merlo A,Pollack JR,Wong AJ

    更新日期:2013-05-23 00:00:00

  • TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.

    abstract::Early Growth Response 1 (EGR1) is a stress response transcription factor with multiple tumour suppressor roles in breast tissue, whose expression is often lost in breast cancers. We have previously shown that the breast cancer oncogene TBX2 (T-BOX2) interacts with EGR1 to co-repress EGR1-target genes including the bre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0853-z

    authors: Crawford NT,McIntyre AJ,McCormick A,D'Costa ZC,Buckley NE,Mullan PB

    更新日期:2019-08-01 00:00:00

  • Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer.

    abstract::Axl is a receptor that induces proliferation, migration and invasion in cancer. In this study, we show that specific microRNAs (miRNAs) target the 3'-UTR of Axl. Luciferase-reporter assays with wild-type and deleted miR-34 and miR-199a/b seed sequences of Axl 3'-UTR confirmed the specificity of targeting. An inverse c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.13

    authors: Mudduluru G,Ceppi P,Kumarswamy R,Scagliotti GV,Papotti M,Allgayer H

    更新日期:2011-06-23 00:00:00

  • Phorbol esters inhibit fibroblast growth factor-2-stimulated fibroblast proliferation by a p38 MAP kinase dependent pathway.

    abstract::Treatment of fibroblasts with the phorbol ester, 12-O-tetradecanoyl phorbol 13-acetate (TPA), specifically inhibits fibroblast growth factor-2 (FGF-2) induced proliferation. TPA treatment has little or no effect on FGF receptor activation but specifically inhibits the activation of p38 MAPK but not other downstream si...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205268

    authors: Maher P

    更新日期:2002-03-27 00:00:00

  • Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation.

    abstract::Silencing of gene expression by methylation of CpG islands in regulatory elements is frequently observed in cancer. However, an influence of the most common oncogenic signalling pathways onto DNA methylation has not yet been investigated thoroughly. To address this issue, we identified genes suppressed in HRAS-transfo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209502

    authors: Lund P,Weisshaupt K,Mikeska T,Jammas D,Chen X,Kuban RJ,Ungethüm U,Krapfenbauer U,Herzel HP,Schäfer R,Walter J,Sers C

    更新日期:2006-08-10 00:00:00

  • Molecular cloning of the epidermal growth factor-stimulated protein kinase p56 KKIAMRE.

    abstract::A 56 kDa protein kinase was molecularly cloned from human fetal brain. This protein kinase (p56 KKIAMRE) shares homology with p42 KKIALRE (Meyerson et al., 1992) and is related to the proline-directed protein kinase group of signal transducing enzymes. The p56 KKIAMRE and p42 KKIALRE protein kinases exhibit mutually e...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Taglienti CA,Wysk M,Davis RJ

    更新日期:1996-12-19 00:00:00

  • MAGI-3 is involved in the regulation of the JNK signaling pathway as a scaffold protein for frizzled and Ltap.

    abstract::A seven-transmembrane protein, frizzled, has been implicated in a planar cell polarity (PCP) pathway as well as the canonical Wnt signaling pathway. Although both pathways require a cytoplasmic protein, dishevelled, the molecular mechanism by which frizzled regulates intracellular signaling remains to be elucidated. I...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207817

    authors: Yao R,Natsume Y,Noda T

    更新日期:2004-08-12 00:00:00

  • Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression.

    abstract::Abundant data support a key role for the transcription factor nuclear factor-kappaB (NF-kappaB) signaling pathway in controlling the initiation and progression of human cancer. NF-kappaB and associated regulatory proteins such as IkappaB kinase (IKK) are activated downstream of many oncoproteins and there is much evid...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209942

    authors: Bassères DS,Baldwin AS

    更新日期:2006-10-30 00:00:00

  • Promoter specificity and stability control of the p53-related protein p73.

    abstract::The p53 family of proteins play instrumental roles in mediating the cellular response to stress. The p53-related gene product, p73, occurs as two distinct protein isoforms, referred to as alpha and beta, which differ in the length of the C-terminal region and arise through alternative splicing of the p73 RNA. Here, we...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202793

    authors: Lee CW,La Thangue NB

    更新日期:1999-07-22 00:00:00

  • Apoptosis in v-myc transformation of myelomonocytic cells and its modulation by CSF-1.

    abstract::c-myc is a proto-oncogene essential for cell growth. When activated, its expression can lead to uncontrolled cell proliferation, transformation and tumorigenesis. The cell line tEMmyc4 is a murine myelomonocytic cell line that was established following transformation by v-myc. It has a high level of v-myc expression a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Dolnikov A,Ward RL,Hawkins NJ,Symonds G

    更新日期:1996-03-21 00:00:00

  • Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.

    abstract::Chromosomal aberrations are a hallmark of human cancers, with complex cytogenetic rearrangements leading to genetic changes permissive for cancer initiation and progression. Protection of Telomere 1 (POT1) is an essential component of the shelterin complex and functions to maintain chromosome stability by repressing t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.405

    authors: Gu P,Wang Y,Bisht KK,Wu L,Kukova L,Smith EM,Xiao Y,Bailey SM,Lei M,Nandakumar J,Chang S

    更新日期:2017-04-06 00:00:00

  • CHF: a novel factor binding to cyclin A CHR corepressor element.

    abstract::Cell cycle modulation of cyclin A expression is due to the periodic relief of a transcriptional repression mediated by a bipartite negative DNA regulatory region. The 5' element (Cell Cycle Responsive Element: CCRE; cell Cycle Dependent Element: CDE) is clearly occupied in a cyclic manner in vivo, whereas the 3' eleme...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203017

    authors: Philips A,Chambeyron S,Lamb N,Vié A,Blanchard JM

    更新日期:1999-11-04 00:00:00

  • The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene.

    abstract::The BCL6 gene, mapped at the chromosomal band 3q27, encodes a POZ/Zinc finger transcription repressor protein. It is frequently activated in Non-Hodgkin's lymphomas (NHL) by translocations with breakpoints clustering in the 5' major breakpoint region (MBR) as well as by mutations in the same region. The translocations...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202098

    authors: Chen W,Butler M,Rao PH,Chaganti SR,Louie DC,Dalla-Favera R,Chaganti RS

    更新日期:1998-10-01 00:00:00

  • Evidence for GEAPS, novel Glial E2F1-Associated Proteins in hamster glioma cells induced by the human neurotropic polyomavirus, JCV.

    abstract::Injection of the human neurotropic polyomavirus, JCV, into neonatal hamsters causes tumors of glial origin. Previously, a rapidly proliferating cell line, HJC-15, which expresses high levels of the viral T-antigen, had been established from JCV-induced hamster glial tumors. In our analyses of the mechanisms involved i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Raj GV,Ansari SA,Khalili K

    更新日期:1996-03-21 00:00:00

  • Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2.

    abstract::The epidermal growth factor receptor (EGFR) is activated by a variety of ligands including EGF and transforming growth factor-alpha (TGFalpha), whereas no ligand for the homologous ErbB2 oncoprotein has yet been identified. Here we use both an ErbB2 phosphoantibody (aPY1222) and an activation-specific EGFR antibody to...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201595

    authors: Gulliford TJ,Huang GC,Ouyang X,Epstein RJ

    更新日期:1997-10-01 00:00:00